Results 231 to 240 of about 213,806 (248)

PARP-1 couples β-catenin/TCF4 signaling to epithelial-mesenchymal transition in endometriosis. [PDF]

Sci Rep
Zhang L, Li X, Kong L, Hou X, Li B, Zhang Y, Wang J.   +6 more
europepmc   +1 more source

Recognition of immunogenomic signature and prognostic value of the subtype of epithelial-mesenchymal transition in breast cancer. [PDF]

Biochem Biophys Rep
Liang W, Wang ZY, Shao QF, Li YY, Zhu B, Qin XH, Chen WX.   +6 more
europepmc   +1 more source

Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer. [PDF]

NPJ Precis Oncol
Zhou X, Xie L, Liu J, Liao G, Yang H.
europepmc   +1 more source

Anlotinib ameliorates myositis-associated interstitial lung disease (MAILD) via suppression of the NETs-PI3K/Akt-driven epithelial-mesenchymal transition. [PDF]

RMD Open
Yang J, Chai H, Zhu J, Cui X, Li W, Su Q, Guo Z, Feng Y, Zhang S.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

Journal of Cellular Physiology, 2019
Epithelial–mesenchymal transition (EMT) is a key step in transdifferentiation process in solid cancer development. Forthcoming evidence suggest that the stratified program transforms polarized, immotile epithelial cells to migratory mesenchymal cells ...
Vishal Das, Sourya Bhattacharya, C. Chikkaputtaiah, Saugata Hazra, Mintu Pal   +4 more
semanticscholar   +1 more source